Hyperthyroidism in non-seminomatous testicular germ cell tumors

Standard

Hyperthyroidism in non-seminomatous testicular germ cell tumors : two case reports and literature review. / Favero, Diletta; Oing, Christoph; Seidel, Christoph; Rescigno, Pasquale; Catalano, Fabio; Cremante, Malvina; Rebuzzi, Sara Elena; Gatto, Federico; Rosti, Giovanni; Ferone, Diego; Fornarini, Giuseppe; Cocchiara, Francesco.

In: FRONT ONCOL, Vol. 14, 1338438, 2024.

Research output: SCORING: Contribution to journalCase reportResearchpeer-review

Harvard

Favero, D, Oing, C, Seidel, C, Rescigno, P, Catalano, F, Cremante, M, Rebuzzi, SE, Gatto, F, Rosti, G, Ferone, D, Fornarini, G & Cocchiara, F 2024, 'Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review', FRONT ONCOL, vol. 14, 1338438. https://doi.org/10.3389/fonc.2024.1338438

APA

Favero, D., Oing, C., Seidel, C., Rescigno, P., Catalano, F., Cremante, M., Rebuzzi, S. E., Gatto, F., Rosti, G., Ferone, D., Fornarini, G., & Cocchiara, F. (2024). Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review. FRONT ONCOL, 14, [1338438]. https://doi.org/10.3389/fonc.2024.1338438

Vancouver

Bibtex

@article{3c3d3e753c514874b45d7845bd0ab486,
title = "Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review",
abstract = "BACKGROUND: Human chorionic gonadotropin (hCG)-induced hyperthyroidism is a rare paraneoplastic syndrome observed in non-seminomatous testicular germ cell tumors, due to a cross-reaction between the β-subunit of hCG with the thyroid-stimulating hormone receptor. The precise prevalence of this paraneoplastic phenomenon is unclear as, in the majority of cases, hyperthyroidism remains subclinical.CASE PRESENTATION: Here, we present two cases of advanced metastatic non-seminomatous testicular germ cell tumors where patients exhibited signs and symptoms of thyrotoxicosis at primary diagnosis due to excessive serum β-hCG elevation, with complete remission of symptomatology after the start of oncological treatments and no signs of relapse at the time of publication of this report. Additionally, we provide a comprehensive review of the existing literature concerning this uncommon occurrence.CONCLUSION: Despite being a rare event, the presence of hyperthyroidism or thyrotoxicosis without clear etiology in a young man should lead to consider less frequent causes such as testicular tumors. Even if patients typically have mild symptoms that resolve after chemotherapy, in rare cases, it can be a life-threatening condition that requires prompt recognition and specific intervention.",
author = "Diletta Favero and Christoph Oing and Christoph Seidel and Pasquale Rescigno and Fabio Catalano and Malvina Cremante and Rebuzzi, {Sara Elena} and Federico Gatto and Giovanni Rosti and Diego Ferone and Giuseppe Fornarini and Francesco Cocchiara",
note = "Case Report",
year = "2024",
doi = "10.3389/fonc.2024.1338438",
language = "English",
volume = "14",
journal = "FRONT ONCOL",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",

}

RIS

TY - JOUR

T1 - Hyperthyroidism in non-seminomatous testicular germ cell tumors

T2 - two case reports and literature review

AU - Favero, Diletta

AU - Oing, Christoph

AU - Seidel, Christoph

AU - Rescigno, Pasquale

AU - Catalano, Fabio

AU - Cremante, Malvina

AU - Rebuzzi, Sara Elena

AU - Gatto, Federico

AU - Rosti, Giovanni

AU - Ferone, Diego

AU - Fornarini, Giuseppe

AU - Cocchiara, Francesco

N1 - Case Report

PY - 2024

Y1 - 2024

N2 - BACKGROUND: Human chorionic gonadotropin (hCG)-induced hyperthyroidism is a rare paraneoplastic syndrome observed in non-seminomatous testicular germ cell tumors, due to a cross-reaction between the β-subunit of hCG with the thyroid-stimulating hormone receptor. The precise prevalence of this paraneoplastic phenomenon is unclear as, in the majority of cases, hyperthyroidism remains subclinical.CASE PRESENTATION: Here, we present two cases of advanced metastatic non-seminomatous testicular germ cell tumors where patients exhibited signs and symptoms of thyrotoxicosis at primary diagnosis due to excessive serum β-hCG elevation, with complete remission of symptomatology after the start of oncological treatments and no signs of relapse at the time of publication of this report. Additionally, we provide a comprehensive review of the existing literature concerning this uncommon occurrence.CONCLUSION: Despite being a rare event, the presence of hyperthyroidism or thyrotoxicosis without clear etiology in a young man should lead to consider less frequent causes such as testicular tumors. Even if patients typically have mild symptoms that resolve after chemotherapy, in rare cases, it can be a life-threatening condition that requires prompt recognition and specific intervention.

AB - BACKGROUND: Human chorionic gonadotropin (hCG)-induced hyperthyroidism is a rare paraneoplastic syndrome observed in non-seminomatous testicular germ cell tumors, due to a cross-reaction between the β-subunit of hCG with the thyroid-stimulating hormone receptor. The precise prevalence of this paraneoplastic phenomenon is unclear as, in the majority of cases, hyperthyroidism remains subclinical.CASE PRESENTATION: Here, we present two cases of advanced metastatic non-seminomatous testicular germ cell tumors where patients exhibited signs and symptoms of thyrotoxicosis at primary diagnosis due to excessive serum β-hCG elevation, with complete remission of symptomatology after the start of oncological treatments and no signs of relapse at the time of publication of this report. Additionally, we provide a comprehensive review of the existing literature concerning this uncommon occurrence.CONCLUSION: Despite being a rare event, the presence of hyperthyroidism or thyrotoxicosis without clear etiology in a young man should lead to consider less frequent causes such as testicular tumors. Even if patients typically have mild symptoms that resolve after chemotherapy, in rare cases, it can be a life-threatening condition that requires prompt recognition and specific intervention.

U2 - 10.3389/fonc.2024.1338438

DO - 10.3389/fonc.2024.1338438

M3 - Case report

C2 - 38601761

VL - 14

JO - FRONT ONCOL

JF - FRONT ONCOL

SN - 2234-943X

M1 - 1338438

ER -